Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy.

Liu, Yuan-Yuan; Zhao, Ren-Feng; Liu, Chao; Zhou, Jie; Yang, Liu; Li, Li

Liu, Yuan-Yuan; Zhao, Ren-Feng; Liu, Chao; Zhou, Jie; Yang, Liu; Li, Li.

Affiliation

Liu YY; Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, People's Republic of China.
Zhao RF; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Liu C; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Zhou J; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Yang L; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.
Li L; The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.

Int J Gen Med ; 15: 123-131, 2022.

Article in En | MEDLINE | ID: mdl-35023951

Key words

SEER; external verification; nomograms; overall survival; serous ovarian cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Int J Gen Med Year: 2022 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google